Name
RF01-01 - SERENA-3: A randomized pre-surgical window of opportunity study assessing dose and duration of camizestrant treatment in post-menopausal women with ER-positive, HER2-negative primary cancer
Date & Time
Wednesday, December 6, 2023
Speakers
Virtual Session Link
Total Minutes
4:46
OnDemand Video URL